{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:47:26Z","timestamp":1787064446789,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatocellular carcinoma (HCC) remains the most prevalent type of primary liver cancer worldwide. p53 is one of the most frequently mutated tumor-suppressor genes in HCC and its deficiency in hepatocytes triggers tumor formation in mice. To investigate iron metabolism during liver carcinogenesis, we employed a model of chronic carbon tetrachloride injections in liver-specific p53-deficient mice to induce liver fibrosis, cirrhosis and subsequent carcinogenesis. A transcriptome analysis of liver carcinoma was employed to identify p53-dependent gene expression signatures with subsequent in-depth analysis of iron metabolic parameters being conducted locally within liver cancers and at systemic levels. We show that all mutant mice developed liver cancer by 36-weeks of age in contrast to 3.4% tumors identified in control mice. All liver cancers with a p53-deficient background exhibited a local iron-poor phenotype with a \u201chigh transferrin receptor 1 (\n                    <jats:italic>Tfr1<\/jats:italic>\n                    ) and low hepcidin (\n                    <jats:italic>Hamp<\/jats:italic>\n                    )\u201d signature. At systemic levels, iron deficiency was restricted to female mice. Additionally, liver tumorigenesis correlated with selective deficits of selenium, zinc and manganese. Our data show that iron deficiency is a prevalent phenomenon in p53-deficient liver cancers, which is associated with alterations in\n                    <jats:italic>Hamp<\/jats:italic>\n                    and\n                    <jats:italic>Tfr1<\/jats:italic>\n                    and a poor prognosis in mice and patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-86486-x","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:20:51Z","timestamp":1737015651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Iron metabolism in a mouse model of hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Dilay","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Tharehalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Paganoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Leith\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vuji\u0107 Spasi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"86486_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA. Cancer J. Clin."},{"issue":"1","key":"86486_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7(1), 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"86486_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh, J. et al. Hepatocellular carcinoma: A review. J. Hepatocell. Carcinoma 3, 41\u201353. https:\/\/doi.org\/10.2147\/JHC.S61146 (2016).","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"9","key":"86486_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gr.154492.113","volume":"23","author":"Z Kan","year":"2013","unstructured":"Kan, Z. et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome. Res. 23(9), 1422\u20131433. https:\/\/doi.org\/10.1101\/gr.154492.113 (2013).","journal-title":"Genome. Res."},{"issue":"2","key":"86486_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.canlet.2012.09.027","volume":"340","author":"S Li","year":"2013","unstructured":"Li, S. & Mao, M. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas. Cancer Lett. 340(2), 247\u2013253. https:\/\/doi.org\/10.1016\/j.canlet.2012.09.027 (2013).","journal-title":"Cancer Lett."},{"issue":"5","key":"86486_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47(5), 505\u2013511. https:\/\/doi.org\/10.1038\/ng.3252 (2015).","journal-title":"Nat. Genet."},{"issue":"7\u20138","key":"86486_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00018-003-3304-4","volume":"61","author":"K Harms","year":"2004","unstructured":"Harms, K., Nozell, S. & Chen, X. The common and distinct target genes of the p53 family transcription factors. Cell Mol. Life Sci. 61(7\u20138), 822\u2013842. https:\/\/doi.org\/10.1007\/s00018-003-3304-4 (2004).","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"86486_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3978\/j.issn.2304-3881.2014.01.03","volume":"3","author":"P Zhan","year":"2014","unstructured":"Zhan, P. & Ji, Y. N. Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg. Nutr. 3(1), 11\u201317. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.01.03 (2014).","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"1","key":"86486_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/mco.2023.2650","volume":"19","author":"N Rahadiani","year":"2023","unstructured":"Rahadiani, N., Stephanie, M., Perkasa, A. G., Handjari, D. R. & Krisnuhoni, E. p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma. Mol. Clin. Oncol. 19(1), 54. https:\/\/doi.org\/10.3892\/mco.2023.2650 (2023).","journal-title":"Mol. Clin. Oncol."},{"issue":"5","key":"86486_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1053\/j.gastro.2012.02.009","volume":"142","author":"SF Katz","year":"2012","unstructured":"Katz, S. F. et al. Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology 142(5), 1229-1239 e3. https:\/\/doi.org\/10.1053\/j.gastro.2012.02.009 (2012).","journal-title":"Gastroenterology"},{"issue":"10","key":"86486_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/ng.426","volume":"41","author":"Y Begus-Nahrmann","year":"2009","unstructured":"Begus-Nahrmann, Y. et al. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat. Genet. 41(10), 1138\u20131143. https:\/\/doi.org\/10.1038\/ng.426 (2009).","journal-title":"Nat. Genet."},{"key":"86486_CR12","doi-asserted-by":"crossref","unstructured":"Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev 14(8) 994\u20131004 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10783170 (2000)","DOI":"10.1101\/gad.14.8.994"},{"key":"86486_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molmet.2019.10.002","volume":"33","author":"M Lacroix","year":"2020","unstructured":"Lacroix, M., Riscal, R., Arena, G., Linares, L. K. & Le Cam, L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol. Metab. 33, 2\u201322. https:\/\/doi.org\/10.1016\/j.molmet.2019.10.002 (2020).","journal-title":"Mol. Metab."},{"issue":"49","key":"86486_CR14","doi-asserted-by":"publisher","first-page":"33911","DOI":"10.1074\/jbc.M806432200","volume":"283","author":"F Zhang","year":"2008","unstructured":"Zhang, F., Wang, W., Tsuji, Y., Torti, S. V. & Torti, F. M. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J. Biol. Chem. 283(49), 33911\u201333918. https:\/\/doi.org\/10.1074\/jbc.M806432200 (2008).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"86486_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/nu9121335","volume":"9","author":"N Zhao","year":"2017","unstructured":"Zhao, N. et al. The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14. Nutrients 9(12), 1335. https:\/\/doi.org\/10.3390\/nu9121335 (2017).","journal-title":"Nutrients"},{"issue":"12","key":"86486_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1101\/gad.299388.117","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. Genes. Dev. 31(12), 1243\u20131256. https:\/\/doi.org\/10.1101\/gad.299388.117 (2017).","journal-title":"Genes. Dev."},{"issue":"2","key":"86486_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2141.2007.06638.x","volume":"138","author":"O Weizer-Stern","year":"2007","unstructured":"Weizer-Stern, O. et al. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br. J. Haematol. 138(2), 253\u2013262. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06638.x (2007).","journal-title":"Br. J. Haematol."},{"key":"86486_CR18","doi-asserted-by":"publisher","first-page":"16497","DOI":"10.1038\/srep16497","volume":"5","author":"Y Funauchi","year":"2015","unstructured":"Funauchi, Y. et al. Regulation of iron homeostasis by the p53-ISCU pathway. Sci. Rep. 5, 16497. https:\/\/doi.org\/10.1038\/srep16497 (2015).","journal-title":"Sci. Rep."},{"issue":"2","key":"86486_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13238-014-0119-z","volume":"6","author":"C Zhang","year":"2015","unstructured":"Zhang, C. & Zhang, F. Iron homeostasis and tumorigenesis: Molecular mechanisms and therapeutic opportunities. Protein Cell 6(2), 88\u2013100. https:\/\/doi.org\/10.1007\/s13238-014-0119-z (2015).","journal-title":"Protein Cell"},{"key":"86486_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fonc.2020.00476","volume":"10","author":"RAM Brown","year":"2020","unstructured":"Brown, R. A. M. et al. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front. Oncol. 10, 476. https:\/\/doi.org\/10.3389\/fonc.2020.00476 (2020).","journal-title":"Front. Oncol."},{"key":"86486_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100860","volume":"75","author":"SV Torti","year":"2020","unstructured":"Torti, S. V. & Torti, F. M. Iron: The cancer connection. Mol. Asp. Med. 75, 100860. https:\/\/doi.org\/10.1016\/j.mam.2020.100860 (2020).","journal-title":"Mol. Asp. Med."},{"key":"86486_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N. & Torti, F. M. Iron and Cancer. Annu. Rev. Nutr. 38, 97\u2013125. https:\/\/doi.org\/10.1146\/annurev-nutr-082117-051732 (2018).","journal-title":"Annu. Rev. Nutr."},{"issue":"9","key":"86486_CR23","doi-asserted-by":"publisher","first-page":"C728","DOI":"10.1152\/ajpcell.00322.2015","volume":"310","author":"P Chanvorachote","year":"2016","unstructured":"Chanvorachote, P. & Luanpitpong, S. Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells. Am. J. Physiol. Cell Physiol. 310(9), C728\u2013C739. https:\/\/doi.org\/10.1152\/ajpcell.00322.2015 (2016).","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"86486_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1124\/mol.112.081893","volume":"83","author":"GY Lui","year":"2013","unstructured":"Lui, G. Y. et al. The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action. Mol. Pharmacol. 83(1), 179\u2013190. https:\/\/doi.org\/10.1124\/mol.112.081893 (2013).","journal-title":"Mol. Pharmacol."},{"key":"86486_CR25","unstructured":"Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang P. Transferrin receptor 1 in cancer: a new sight for cancer therapy Am. J. Cancer Res. 8(6) 916\u2013931 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30034931 (2018)"},{"issue":"1","key":"86486_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/his.13847","volume":"75","author":"M Adachi","year":"2019","unstructured":"Adachi, M. et al. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma. Histopathology 75(1), 63\u201373. https:\/\/doi.org\/10.1111\/his.13847 (2019).","journal-title":"Histopathology"},{"issue":"4","key":"86486_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2014.10.046","volume":"62","author":"SM Kessler","year":"2015","unstructured":"Kessler, S. M., Barghash, A., Laggai, S., Helms, V. & Kiemer, A. K. Hepatic hepcidin expression is decreased in cirrhosis and HCC. J. Hepatol. 62(4), 977\u2013979. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.046 (2015).","journal-title":"J. Hepatol."},{"key":"86486_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2407-8-167","volume":"8","author":"H Kijima","year":"2008","unstructured":"Kijima, H., Sawada, T., Tomosugi, N. & Kubota, K. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8, 167. https:\/\/doi.org\/10.1186\/1471-2407-8-167 (2008).","journal-title":"BMC Cancer"},{"issue":"10","key":"86486_CR29","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1002\/hep4.2031","volume":"6","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma. Hepatol. Commun. 6(10), 2914\u20132924. https:\/\/doi.org\/10.1002\/hep4.2031 (2022).","journal-title":"Hepatol. Commun."},{"issue":"2","key":"86486_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ymthe.2021.09.012","volume":"30","author":"M Li","year":"2022","unstructured":"Li, M. et al. Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma. Mol. Ther. 30(2), 703\u2013713. https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.012 (2022).","journal-title":"Mol. Ther."},{"issue":"1","key":"86486_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/path.1875","volume":"208","author":"GA Asare","year":"2006","unstructured":"Asare, G. A., Paterson, A. C., Kew, M. C., Khan, S. & Mossanda, K. S. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron. J. Pathol. 208(1), 82\u201390. https:\/\/doi.org\/10.1002\/path.1875 (2006).","journal-title":"J. Pathol."},{"issue":"8","key":"86486_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1478-3231.2006.01316.x","volume":"26","author":"P Holmstrom","year":"2006","unstructured":"Holmstrom, P. et al. Expression of iron regulatory genes in a rat model of hepatocellular carcinoma. Liver Int. 26(8), 976\u2013985. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01316.x (2006).","journal-title":"Liver Int."},{"key":"86486_CR33","unstructured":"Hirota, N., Williams,GM. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation Cancer Res 42(6) 2298\u2013309 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7074612 (1982)"},{"key":"86486_CR34","doi-asserted-by":"crossref","unstructured":"Deugnier YM. et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients Hepatology 18(6) 1363\u20139 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7902316 (1993)","DOI":"10.1016\/0270-9139(93)90225-C"},{"issue":"5834","key":"86486_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317(5834), 121\u2013124. https:\/\/doi.org\/10.1126\/science.1140485 (2007).","journal-title":"Science"},{"issue":"4","key":"86486_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","volume":"90","author":"F Heindryckx","year":"2009","unstructured":"Heindryckx, F., Colle, I. & Van Vlierberghe, H. Experimental mouse models for hepatocellular carcinoma research. Int. J. Exp. Pathol. 90(4), 367\u2013386. https:\/\/doi.org\/10.1111\/j.1365-2613.2009.00656.x (2009).","journal-title":"Int. J. Exp. Pathol."},{"issue":"10","key":"86486_CR37","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/cancers11101410","volume":"11","author":"M Svinarenko","year":"2019","unstructured":"Svinarenko, M. et al. An IKK\/NF-kappaB activation\/p53 Deletion sequence drives liver carcinogenesis and tumor differentiation. Cancers (Basel) 11(10), 1410. https:\/\/doi.org\/10.3390\/cancers11101410 (2019).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"86486_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jhep.2008.02.001","volume":"48","author":"J Zucman-Rossi","year":"2008","unstructured":"Zucman-Rossi, J. Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations. J. Hepatol. 48(5), 884\u2013886. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.001 (2008).","journal-title":"J. Hepatol."},{"issue":"2","key":"86486_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12870","volume":"48","author":"S Udali","year":"2018","unstructured":"Udali, S. et al. Hepcidin and DNA promoter methylation in hepatocellular carcinoma. Eur. J. Clin. Invest. 48(2), e12870. https:\/\/doi.org\/10.1111\/eci.12870 (2018).","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"86486_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.toxlet.2008.11.002","volume":"184","author":"P Youn","year":"2009","unstructured":"Youn, P. et al. Regulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumors. Toxicol. Lett. 184(3), 151\u2013158. https:\/\/doi.org\/10.1016\/j.toxlet.2008.11.002 (2009).","journal-title":"Toxicol. Lett."},{"issue":"5","key":"86486_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti, S. V. & Torti, F. M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13(5), 342\u2013355. https:\/\/doi.org\/10.1038\/nrc3495 (2013).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"86486_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/gut.46.5.711","volume":"46","author":"C Chapoutot","year":"2000","unstructured":"Chapoutot, C. et al. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 46(5), 711\u2013714. https:\/\/doi.org\/10.1136\/gut.46.5.711 (2000).","journal-title":"Gut"},{"key":"86486_CR43","doi-asserted-by":"crossref","unstructured":"Turlin, B. et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver Hepatology 22(2) 446\u201350 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7635411 (1995)","DOI":"10.1002\/hep.1840220212"},{"issue":"11","key":"86486_CR44","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1172\/JCI41959","volume":"120","author":"U Kossatz","year":"2010","unstructured":"Kossatz, U. et al. The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. J. Clin. Invest. 120(11), 3820\u20133833. https:\/\/doi.org\/10.1172\/JCI41959 (2010).","journal-title":"J. Clin. Invest."},{"issue":"12","key":"86486_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1080\/15592294.2020.1770917","volume":"15","author":"JS Muhammad","year":"2020","unstructured":"Muhammad, J. S., Bajbouj, K., Shafarin, J. & Hamad, M. Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival. Epigenetics 15(12), 1302\u20131318. https:\/\/doi.org\/10.1080\/15592294.2020.1770917 (2020).","journal-title":"Epigenetics"},{"issue":"4","key":"86486_CR46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2018-05-850404","volume":"133","author":"C Fillebeen","year":"2019","unstructured":"Fillebeen, C. et al. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load. Blood 133(4), 344\u2013355. https:\/\/doi.org\/10.1182\/blood-2018-05-850404 (2019).","journal-title":"Blood"},{"issue":"3","key":"86486_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12011-007-0008-x","volume":"118","author":"K Gurusamy","year":"2007","unstructured":"Gurusamy, K. Trace element concentration in primary liver cancers\u2013a systematic review. Biol. Trace. Elem. Res. 118(3), 191\u2013206. https:\/\/doi.org\/10.1007\/s12011-007-0008-x (2007).","journal-title":"Biol. Trace. Elem. Res."},{"issue":"1","key":"86486_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1385\/BTER:95:1:49","volume":"95","author":"H Tashiro","year":"2003","unstructured":"Tashiro, H., Kawamoto, T., Okubo, T. & Koide, O. Variation in the distribution of trace elements in hepatoma. Biol. Trace. Elem. Res. 95(1), 49\u201363. https:\/\/doi.org\/10.1385\/BTER:95:1:49 (2003).","journal-title":"Biol. Trace. Elem. Res."},{"key":"86486_CR49","unstructured":"Gur,G., Bayraktar,Y., Ozer,D., Ozdogan,M., & Kayhan, B. Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus Hepatogastroenterology 45(20) 472\u20136 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9638430 (1998)"},{"issue":"7","key":"86486_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100742","volume":"5","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the liver cancer pooling project. JHEP Rep. 5(7), 100742. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100742 (2023).","journal-title":"JHEP Rep."},{"issue":"1","key":"86486_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12915-023-01595-1","volume":"21","author":"B Fito-Lopez","year":"2023","unstructured":"Fito-Lopez, B., Salvadores, M., Alvarez, M. M. & Supek, F. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors. BMC Biol. 21(1), 92. https:\/\/doi.org\/10.1186\/s12915-023-01595-1 (2023).","journal-title":"BMC Biol."},{"issue":"20","key":"86486_CR52","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1001\/jama.2020.21566","volume":"324","author":"JL Atkins","year":"2020","unstructured":"Atkins, J. L. et al. Association of hemochromatosis HFE p. C282Y homozygosity with hepatic malignancy. JAMA 324(20), 2048\u20132057. https:\/\/doi.org\/10.1001\/jama.2020.21566 (2020).","journal-title":"JAMA"},{"issue":"1","key":"86486_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s0016-5085(99)70562-7","volume":"117","author":"G Vautier","year":"1999","unstructured":"Vautier, G. et al. p53 mutations in british patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis. Gastroenterology 117(1), 154\u2013160. https:\/\/doi.org\/10.1016\/s0016-5085(99)70562-7 (1999).","journal-title":"Gastroenterology"},{"issue":"23","key":"86486_CR54","doi-asserted-by":"publisher","first-page":"12770","DOI":"10.1073\/pnas.220416097","volume":"97","author":"SP Hussain","year":"2000","unstructured":"Hussain, S. P. et al. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: Oxyradical overload diseases. Proc. Natl. Acad. Sci. U S A 97(23), 12770\u201312775. https:\/\/doi.org\/10.1073\/pnas.220416097 (2000).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"86486_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbadis.2012.08.013","volume":"1832","author":"M Vujic Spasic","year":"2013","unstructured":"Vujic Spasic, M. et al. Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload. Biochim. Biophys. Acta. 1832(1), 76\u201384. https:\/\/doi.org\/10.1016\/j.bbadis.2012.08.013 (2013).","journal-title":"Biochim. Biophys. Acta."},{"issue":"24","key":"86486_CR56","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1007\/s00216-020-02614-8","volume":"412","author":"A Gruber","year":"2020","unstructured":"Gruber, A. et al. Total reflection X-ray fluorescence spectrometry for trace determination of iron and some additional elements in biological samples. Anal. Bioanal. Chem. 412(24), 6419\u20136429. https:\/\/doi.org\/10.1007\/s00216-020-02614-8 (2020).","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86486-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86486-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86486-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:20:57Z","timestamp":1737015657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86486-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86486-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2180"}}